[Flavonoids--bioactive compounds in fruits juice]

Area of Science:

• Pharmacology and Pharmacokinetics
• Food Science and Nutrition

Background:

• Grapefruit juice (GFJ) is known to alter the pharmacokinetics of various drugs, including calcium channel blockers and HMGCoA reductase inhibitors.
• These drugs are primarily metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme.
• GFJ contains compounds like flavonoids and furanocoumarins that inhibit the CYP3A4 enzyme system.

Purpose of the Study:

• To comparatively analyze the total flavonoid content in different fruit juices, with a focus on naringin in grapefruit varieties.
• To understand the impact of grapefruit juice consumption on drug metabolism via CYP3A4 inhibition.

Main Methods:

• Comparative analysis of total flavonoid content and naringin concentration in industrial and laboratory-prepared juices.
• Juices analyzed included white, pink, and red grapefruit, as well as apple and pear juices.

Main Results:

• Grapefruit juices exhibited higher concentrations of flavonoidic compounds compared to apple and pear juices.
• Red grapefruit juice had the highest concentration (143.86 mg/100 mL), followed by pink (131.47 mg/100 mL) and white (84.21 mg/100 mL) in total fruit juice.
• Naringin content, a key flavanone, ranged from 1.98 to 51.2 mg/100 mL of juice.

Conclusions:

• Grapefruit juice, particularly red and pink varieties, is rich in flavonoids and furanocoumarins that inhibit CYP3A4.
• The varying flavonoid content across grapefruit types may influence the extent of drug-metabolism interactions.
• Further research into specific compound concentrations and their clinical impact is warranted.